Doctor faces apparent retaliation after alleging data manipulation in published trial

Fouad Fayad

A rheumatologist was suspended from a professional society and his license to practice medicine was threatened after he raised concerns about data manipulation in a published study for which he recruited patients, according to documents seen by Retraction Watch. 

The study, “Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence,” was published in Frontiers in Immunology in 2019 and has been cited 13 times, according to Clarivate’s Web of Science. In its acknowledgements, it listed Fouad Fayad, a rheumatologist at the University of Saint Joseph and Hotel-Dieu de France University Medical Center in Beirut, as one of the researchers who recruited patients for the trial. 

Fayad alleged that the researchers tested patient samples multiple times and used a mix of old and new values in their analysis. After he reported his concerns to the journal and then the university, which both concluded that they could not confirm or refute his allegations, he has faced apparent retaliation, including the suspension of his membership in the Lebanese Society of Rheumatology. 

In comments to Retraction Watch, the corresponding author for the study noted that the two investigations did not find data manipulation, and said the issue was “based on a background of personal and professional conflicts.” 

Continue reading Doctor faces apparent retaliation after alleging data manipulation in published trial

“Data had been manipulated:” Science Translational Medicine retracts paper

Science Translational Medicine has retracted a paper by researchers based in Switzerland, after an investigation concluded two figures had been manipulated.

The investigation occurred at the University of Basel. It’s not clear what prompted it, but the paper has been discussed at length on PubPeer. After the investigation concluded two figure panels included manipulated data, the last author asked to retract the paper.

Here’s the notice:

Continue reading “Data had been manipulated:” Science Translational Medicine retracts paper

A paper was published in 2015; the authors already lost the data

American Journal of Physiology Renal PhsyiologyThe authors of a 2015 study have retracted it after discovering that several Western blots in their paper “do not represent the experiments that were reported.”

They couldn’t check some of the original blots, because — according to the retraction notice in the American Journal of Physiology – Renal Physiology — they could not be located. The ones that could be found, however, are “inconsistent with what is presented in the figures.”

Here’s the retraction notice, published last month: Continue reading A paper was published in 2015; the authors already lost the data

Vanishing citation for vanishing twin paper

AJMB.gifThe author of a paper on the phenomenon of the vanishing twin has lost the article for failure to list his co-author on the article.

The paper, “Genotyping Analysis of Circulating Fetal Cells Reveals High Frequency of Vanishing Twin Following Transfer of Multiple Embryos,” had appeared earlier this year in Avicenna Journal of Medical Biotechnology, a publication of the Avicenna Research Institute, in Tehran, Iran. The author was Hussein Mouawia, a biologist at Lebanese University in Beirut.

According to the retraction notice: Continue reading Vanishing citation for vanishing twin paper

Paper — with longest title ever? — retracted for lack of author approval

inorgchimactaThe journal Inorganica Chimica Acta has retracted a paper it published earlier this year over an authorship dispute involving the lead researcher and his colleagues in France.

The title of the paper — whose bulk alone gave us a headache  — was “Reaction of a bidentate ligands (4,4′-dimethyl 2,2′-bipyridine) with planar-chiral chloro-bridged ruthenium: Synthesis of cis-dicarbonyl[4,4′-dimethyl-2,2′-bipyridine- κO1,κO2]{2-[tricarbonyl(η6-phenylene- κC1)chromium]pyridine-κN}ruthenium hexafluorophosphate” — and it purportedly came from a lab in Beirut.

However, as the retraction notice indicates, that’s not quite so:

Continue reading Paper — with longest title ever? — retracted for lack of author approval

Transplant journal retracts three papers over possible organ trafficking

exptclintransThe journal Experimental and Clinical Transplantation has retracted three papers by a group of Lebanese researchers who appear to have been engaging in illicit trafficking of human kidneys.

According to the notice: Continue reading Transplant journal retracts three papers over possible organ trafficking